Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GRKs-IN-1 hydrochloride, Compound 14as, has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50=130 nM) and GRK5 (IC50=7.1 μM).GRKs-IN-1 hydrochloride is a derivative 14as of paroxetine, shows a 100-fold improvement in cardiomyocyte contractility assays over paroxetine[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 108.00 | |
2 mg | Inquiry | $ 174.00 | |
5 mg | Inquiry | $ 291.00 | |
10 mg | Inquiry | $ 456.00 | |
25 mg | Inquiry | $ 822.00 | |
50 mg | Inquiry | $ 1,360.00 | |
100 mg | Inquiry | $ 1,860.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 312.00 |
Description | GRKs-IN-1 hydrochloride, Compound 14as, has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50=130 nM) and GRK5 (IC50=7.1 μM).GRKs-IN-1 hydrochloride is a derivative 14as of paroxetine, shows a 100-fold improvement in cardiomyocyte contractility assays over paroxetine[1]. |
Molecular Weight | N/A |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 50 mg/mL (102.26 mM), Sonication is recommended.
DMSO: 250 mg/mL (511.31 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCG258208 hydrochloride CCG 258208 Hydrochloride CCG-258208 Hydrochloride CCG-258208 hydrochloride CCG258208 Hydrochloride inhibitor inhibit